Jefferies Financial Group Raises Cigna Group (NYSE:CI) Price Target to $333.00

Cigna Group (NYSE:CI) had its price target raised by stock analysts at Jefferies Financial Group from $310.00 to $333.00 in a research report issued to clients and investors on Monday,MarketScreener reports. The firm currently has a “buy” rating on the health services provider’s stock. Jefferies Financial Group’s price target indicates a potential upside of 15.79% from the company’s current price.

Several other equities analysts have also recently weighed in on CI. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a research note on Saturday. Zacks Research upgraded Cigna Group from a “strong sell” rating to a “hold” rating in a research report on Monday, January 5th. Cantor Fitzgerald reduced their target price on Cigna Group from $365.00 to $325.00 in a report on Friday, October 31st. UBS Group set a $294.00 price target on Cigna Group in a research note on Wednesday, November 12th. Finally, Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $330.00.

Cigna Group Trading Down 2.3%

Shares of Cigna Group stock opened at $287.58 on Monday. The company has a fifty day moving average of $275.46 and a 200 day moving average of $283.64. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $350.00. The company has a market capitalization of $76.82 billion, a P/E ratio of 12.97, a P/E/G ratio of 1.02 and a beta of 0.27. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.76 and a current ratio of 0.74.

Cigna Group (NYSE:CI) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 earnings per share for the quarter, topping analysts’ consensus estimates of $7.88 by $0.20. Cigna Group had a return on equity of 19.46% and a net margin of 2.17%.The firm had revenue of $72.50 billion during the quarter, compared to analyst estimates of $69.53 billion. During the same quarter in the prior year, the company posted $6.64 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts anticipate that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of CI. Solstein Capital LLC bought a new stake in shares of Cigna Group in the 2nd quarter worth about $29,000. Harbor Capital Advisors Inc. raised its position in Cigna Group by 119.5% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 90 shares of the health services provider’s stock worth $26,000 after purchasing an additional 49 shares during the period. Chilton Capital Management LLC bought a new stake in Cigna Group in the second quarter worth about $30,000. Princeton Global Asset Management LLC boosted its position in shares of Cigna Group by 115.6% during the second quarter. Princeton Global Asset Management LLC now owns 97 shares of the health services provider’s stock valued at $32,000 after buying an additional 52 shares during the period. Finally, Beacon Financial Strategies CORP bought a new position in shares of Cigna Group during the fourth quarter valued at approximately $28,000. 86.99% of the stock is owned by hedge funds and other institutional investors.

Cigna Group News Summary

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Several Wall Street firms raised price targets and reiterated buy ratings — Jefferies raised its target to $333 and TD Cowen to $338, signaling analyst confidence in upside and earnings power. Jefferies price target raise TD Cowen price target raise
• Positive Sentiment: Deutsche Bank also nudged its target higher to $304 and kept a buy rating, reinforcing consensus analyst support. Deutsche Bank raise
• Positive Sentiment: Zacks highlighted CI as a top-ranked value stock under its style scores, which supports a longer‑term buy case based on valuation metrics. Zacks analysis
• Neutral Sentiment: Mixed analyst notes published via AmericanBankingNews show conflicting target moves (one note cites a raise to $297 while another reports RBC cutting its target to $333) — overall analyst momentum is positive but not uniform. RBC cut to $333 Price target to $297
• Negative Sentiment: MarketWatch flagged that CI underperformed its competitors on the session, suggesting sector rotation or short‑term selling pressure versus peers as a driver of the share decline. MarketWatch underperformance
• Negative Sentiment: Reports that Cigna will cut roughly 2,000 jobs introduce near‑term uncertainty about execution and could be read as a sign of operational stress even though layoffs may reduce costs over time. Beckers report on layoffs

About Cigna Group

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.